Cornell Pharmaceuticals is an international pharmaceutical company engaged in the development, manufacturing, and commercialization of therapies for the treatment of cancer and infectious diseases in Nigeria, Sierra Leone, Kenya, and eventually all of Sub-Saharan Africa.
Cornell Pharmaceuticals is incorporated in Chicago, Illinois with a mandate to explore oncology opportunities in West Africa.
Cornell Pharmaceuticals expands to Lagos, Nigeria and begins marketing discovery with proprietary therapeutics.
Cornell Pharmaceuticals expands Nigeria operations to Eastern Nigeria, partnering with key distributors to accelerate market entry.
Using the Nigeria playbook, Cornell Pharmaceuticals expands to Sierra Leone and Kenya.
Our vision is to transform the lives of patients, families, and communities across Sub-Saharan Africa. Our mission is to be the number one provider of vital therapeutics in the region. We will accomplish this by increasing access to reliable, high quality, and cost effective life-saving therapeutics.
Our mission is to improve the lives of our patients, create an equitable and just healthcare ecosystem driven by increased access for all, and create self sustaining markets where stakeholders have access to the resources and therapies they need.
Our style of innovation is unique to the realities our patients face on a daily basis. While the latest and greatest innovation might be interesting and valuable to the market, we believe there are gems that current exist and its up to us to be innovative about how we discover, commercialize and market already existing opportunities for innovation.